Breastfeeding Duration and the Risk of Coronary Artery Disease.


Journal

Journal of women's health (2002)
ISSN: 1931-843X
Titre abrégé: J Womens Health (Larchmt)
Pays: United States
ID NLM: 101159262

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 14 12 2018
medline: 2 4 2020
entrez: 8 12 2018
Statut: ppublish

Résumé

Previous studies have suggested that prolonged breastfeeding has beneficial effects on the health of the mother including the reduction of long-term risk of coronary artery disease (CAD). The mechanism of this association remains unclear. We surveyed 643 women aged 40-65 years receiving outpatient care at Stanford University Hospital on their reproductive/lactation history, including 137 women (cases) with clinically confirmed CAD. Survey data were supplemented with traditional risk factor data for CAD obtained from the participant's medical record. We then conducted logistic regression analyses to assess the relationship between breastfeeding duration and case-control status for each of the two separate definitions of duration. The first was based on the participant's single longest duration of breastfeeding considering all live births reported and the second was based on a participant's total duration of breastfeeding summed over all live births. For each of these two definitions, we ran three sequential models each with a different reference group-(1) nulliparous women, (2) parous women that never breastfed, and (3) parous women with a short duration of breastfeeding-successively excluding women in the reference group of the previous model(s). Just over one-half (51.6%) of the women surveyed reported a history of breastfeeding. We found nominally significant associations (p = 0.04-0.12) for our multivariate analyses that modeled maximum duration of breastfeeding. When compared with nulliparous women, parous women who either never breastfed or always breastfed for <5 months had approximately double the risk of CAD. Among parous women, women who breastfeed for ≥5 months at least once in their lifetime had a ∼30% decrease risk of CAD compared with those who did not initiate breastfeeding. Among parous women who breastfed ≥1 month, women who breastfed ≥5 months had ∼50% decreased risk of CAD. We found similar point estimates of effect for analogous analyses modeling maximum breastfeeding duration but p-values for these analyses were not significant. Unadjusted analyses demonstrated higher valued odds ratios and lower p-values suggesting the presence of some confounding by traditional risk factors. Parous women who breastfeed ≥5 months in at least one pregnancy seem to be at decreased risk of CAD later in their life, whereas parous women who either never breastfed or discontinued breastfeeding early seem to be at increased risk. More research is needed to more reliably quantify and determine the nature of the relationship between parity, breastfeeding duration, and risk of CAD.

Sections du résumé

BACKGROUND
Previous studies have suggested that prolonged breastfeeding has beneficial effects on the health of the mother including the reduction of long-term risk of coronary artery disease (CAD). The mechanism of this association remains unclear.
METHODS
We surveyed 643 women aged 40-65 years receiving outpatient care at Stanford University Hospital on their reproductive/lactation history, including 137 women (cases) with clinically confirmed CAD. Survey data were supplemented with traditional risk factor data for CAD obtained from the participant's medical record. We then conducted logistic regression analyses to assess the relationship between breastfeeding duration and case-control status for each of the two separate definitions of duration. The first was based on the participant's single longest duration of breastfeeding considering all live births reported and the second was based on a participant's total duration of breastfeeding summed over all live births. For each of these two definitions, we ran three sequential models each with a different reference group-(1) nulliparous women, (2) parous women that never breastfed, and (3) parous women with a short duration of breastfeeding-successively excluding women in the reference group of the previous model(s).
RESULTS
Just over one-half (51.6%) of the women surveyed reported a history of breastfeeding. We found nominally significant associations (p = 0.04-0.12) for our multivariate analyses that modeled maximum duration of breastfeeding. When compared with nulliparous women, parous women who either never breastfed or always breastfed for <5 months had approximately double the risk of CAD. Among parous women, women who breastfeed for ≥5 months at least once in their lifetime had a ∼30% decrease risk of CAD compared with those who did not initiate breastfeeding. Among parous women who breastfed ≥1 month, women who breastfed ≥5 months had ∼50% decreased risk of CAD. We found similar point estimates of effect for analogous analyses modeling maximum breastfeeding duration but p-values for these analyses were not significant. Unadjusted analyses demonstrated higher valued odds ratios and lower p-values suggesting the presence of some confounding by traditional risk factors.
CONCLUSIONS
Parous women who breastfeed ≥5 months in at least one pregnancy seem to be at decreased risk of CAD later in their life, whereas parous women who either never breastfed or discontinued breastfeeding early seem to be at increased risk. More research is needed to more reliably quantify and determine the nature of the relationship between parity, breastfeeding duration, and risk of CAD.

Identifiants

pubmed: 30523760
doi: 10.1089/jwh.2018.6970
pmc: PMC6422010
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

30-36

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL098049
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Am J Perinatol. 2009 Jan;26(1):81-8
pubmed: 19031350
Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1667-72
pubmed: 1750458
Am J Clin Nutr. 1997 Nov;66(5):1116-24
pubmed: 9356528
JAMA. 2005 Nov 23;294(20):2601-10
pubmed: 16304074
Obstet Gynecol. 2007 Mar;109(3):729-38
pubmed: 17329527
Am J Epidemiol. 2011 Nov 15;174(10):1147-58
pubmed: 21997568
Br J Obstet Gynaecol. 1982 Mar;89(3):211-5
pubmed: 7066258
Gynecol Obstet Invest. 2006;61(2):115-8
pubmed: 16272815
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Clin Lab. 2007;53(3-4):173-7
pubmed: 17447654
J Am Heart Assoc. 2017 Jun 21;6(6):
pubmed: 28637778
Am J Clin Nutr. 1993 Aug;58(2):162-6
pubmed: 8338042
Am J Obstet Gynecol. 2008 Mar;198(3):268.e1-6
pubmed: 18191796
J Nutr. 2001 Jan;131(1):53-8
pubmed: 11208938
Obstet Gynecol. 2009 May;113(5):974-82
pubmed: 19384111
Zhonghua Fu Chan Ke Za Zhi. 1994 Mar;29(3):135-7, 188
pubmed: 8082426
BMC Public Health. 2013 Nov 13;13:1070
pubmed: 24219620
Metabolism. 1992 Dec;41(12):1327-30
pubmed: 1461138
Matern Child Health J. 2012 Feb;16(2):316-21
pubmed: 21404071
Prev Med. 2005 Aug;41(2):433-8
pubmed: 15917038
Am J Obstet Gynecol. 2009 Feb;200(2):138.e1-8
pubmed: 19110223
J Clin Endocrinol Metab. 1985 Mar;60(3):542-7
pubmed: 3972965
Annu Rev Nutr. 2016 Jul 17;36:627-45
pubmed: 27146017
Obstet Gynecol. 2002 Aug;100(2):245-52
pubmed: 12151145

Auteurs

Sheeva Rajaei (S)

1 Department of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California.

Joseph Rigdon (J)

2 Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California.

Susan Crowe (S)

3 Department of Obstetrics and Gynecology, Stanford University School of Medicine, Palo Alto, California.

Jennifer Tremmel (J)

1 Department of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California.

Sandra Tsai (S)

4 Department of Internal Medicine, Stanford University School of Medicine, Palo Alto, California.

Themistocles L Assimes (TL)

1 Department of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH